You spoke and we listened!
We are updating our catalogue and some of our EQA schemes based on your feedback to better meet the needs of laboratories.
- We have reduced the maximum number of molecular pathology cases from ten to five, to save analysis costs and time.
- We are increasing the number of schemes for which we offer “virtual” cases, to enable the inclusion of rare genotypes and reduce analysis costs. However, we will still provide cases with corresponding DNA samples for all our EQA schemes, to ensure the whole laboratory analytical pipeline is tested from sample receipt to reporting.
- We have improved our online catalogue to allow purchasing of additional samples (where available); these can now be purchased with the scheme without having to order a separate item.
- We are piloting flexible EQA options, allowing you to participate in schemes that better align with your laboratory practices and diagnostic service scope.
- We aim to make the purchase process faster, smoother and with more visibility for all participants.
Feel free to explore our website further, and subscribe to our newsletter to stay up to date on where we’re going next.
